speb/financial-data huggingface dataset:
DuPont ROE decomposition for IPAR (quarterly period ending 2026-03-31)
ROE: 5.116269417335566%
Net margin: 16.441132551430186%
Asset turnover: 0.2205125204961204
Equity multiplier (leverage): 1.4111995257550385
EBIT margin: 21.495281035707556%
Interest burden factor: 1.0144603016159928
Tax burden factor: 0.7539690982102492
ROE archetype: Standard Business
DuPont ROE decomposition for IPCALAB.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.4072737710128287
ROE archetype: Standard Business
DuPont ROE decomposition for IPCALAB.NS (quarterly period ending 2025-03-31)
ROE: 0.8085099788156556%
Net margin: 3.018663010918284%
Asset turnover: 0.1910361335141639
Equity multiplier (leverage): 1.4020233015866204
EBIT margin: 14.632192247261525%
Interest burden factor: 0.38936545598345196
Tax burden factor: 0.5298437500000001
ROE archetype: Low Return
DuPont ROE decomposition for IPCALAB.NS (quarterly period ending 2025-06-30)
Net margin: 10.100699482426316%
EBIT margin: 13.702059466834134%
Interest burden factor: 1.0447275256037427
Tax burden factor: 0.7056064869444193
ROE archetype: Standard Business
DuPont ROE decomposition for IPCALAB.NS (quarterly period ending 2025-09-30)
ROE: 3.1871840393781965%
Net margin: 11.053002151378838%
Asset turnover: 0.2084784214844088
Equity multiplier (leverage): 1.3831388410773058
EBIT margin: 17.273225112458437%
Interest burden factor: 0.8867501528567223
Tax burden factor: 0.7216149956586139
ROE archetype: Low Return
DuPont ROE decomposition for IPCALAB.NS (quarterly period ending 2025-12-31)
Net margin: 15.200417972831767%
EBIT margin: 17.795611285266457%
Interest burden factor: 1.047491544532131
Tax burden factor: 0.8154401542670076
ROE archetype: Standard Business
DuPont ROE decomposition for IPCALAB.NS (quarterly period ending 2026-03-31)
ROE: 3.2201603097838523%
Net margin: 12.840383842443728%
Asset turnover: 0.1930835338826647
Equity multiplier (leverage): 1.2988357906187067
EBIT margin: 15.772792738478028%
Interest burden factor: 1.0735805484033658
Tax burden factor: 0.7582890344912844
ROE archetype: Low Return
DuPont ROE decomposition for IPD.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.032591725214676
ROE archetype: Standard Business
DuPont ROE decomposition for IPM (quarterly period ending 2025-03-31)
ROE: 3.8362918341354293%
Net margin: 14.652490613511542%
Asset turnover: 0.17720993201197338
Equity multiplier (leverage): 1.477447735013502
EBIT margin: -24.173936460749275%
ROE archetype: Low Return
DuPont ROE decomposition for IPM (quarterly period ending 2025-06-30)
ROE: -5.126266837628803%
Net margin: -18.348795713276434%
Asset turnover: 0.1877022899988423
Equity multiplier (leverage): 1.4884151167527402
EBIT margin: -19.741012781080762%
ROE archetype: Low Return
DuPont ROE decomposition for IPM (quarterly period ending 2025-09-30)
ROE: -5.603906606972102%
Net margin: -17.362403032116447%
Asset turnover: 0.21859440023685778
Equity multiplier (leverage): 1.4765291428548366
EBIT margin: -14.885831543635888%
ROE archetype: Low Return
DuPont ROE decomposition for IPM (quarterly period ending 2025-12-31)
ROE: -3.4207325128049186%
Net margin: -10.303037120690052%
Asset turnover: 0.23025830150256063
Equity multiplier (leverage): 1.4419113293117303
EBIT margin: -9.931717728789138%
ROE archetype: Low Return
DuPont ROE decomposition for IPM (quarterly period ending 2026-03-31)
ROE: -3.703688016958066%
Net margin: -10.389297708124205%
Asset turnover: 0.2286973725762932
Equity multiplier (leverage): 1.5587879144187964
EBIT margin: -10.489364571483604%
ROE archetype: Low Return
DuPont ROE decomposition for IPX (annual period ending 2021-06-30)
ROE: -751.7008499420494%
Asset turnover: 0
Equity multiplier (leverage): 1.5860753812240074
ROE archetype: Low Return
DuPont ROE decomposition for IPX (annual period ending 2022-06-30)
ROE: -468.88048908047296%
Asset turnover: 0
Equity multiplier (leverage): 1.3834852659180623
ROE archetype: Low Return
DuPont ROE decomposition for IPX (annual period ending 2023-06-30)
ROE: -124.68132109173492%
Asset turnover: 0
Equity multiplier (leverage): 1.1689985332852897
ROE archetype: Low Return
DuPont ROE decomposition for IPX (annual period ending 2024-06-30)
ROE: -60.75879941459322%
Asset turnover: 0
Equity multiplier (leverage): 1.0881273604514805
ROE archetype: Low Return
DuPont ROE decomposition for IRISDOREME.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.9357902524003086
ROE archetype: Standard Business
DuPont ROE decomposition for IRISDOREME.NS (quarterly period ending 2024-12-31)
Net margin: 7.112959428566292%
EBIT margin: 12.726624460310942%
Interest burden factor: 0.7481401261889067
Tax burden factor: 0.7470577128831267
ROE archetype: Standard Business
DuPont ROE decomposition for IRISDOREME.NS (quarterly period ending 2025-03-31)
ROE: 5.44711662913401%
Net margin: 11.148504114059437%
Asset turnover: 0.25645677367994
Equity multiplier (leverage): 1.905179506562037
EBIT margin: 17.638470186749444%
Interest burden factor: 0.8635370101391846
Tax burden factor: 0.731938728852309
ROE archetype: Standard Business
DuPont ROE decomposition for IRISDOREME.NS (quarterly period ending 2025-06-30)
Net margin: 7.032540977031472%
EBIT margin: 11.18933661327843%
Interest burden factor: 0.8680909025736612
Tax burden factor: 0.7240069369890164
ROE archetype: Standard Business
DuPont ROE decomposition for IRISDOREME.NS (quarterly period ending 2025-12-31)
Net margin: 6.187227747185009%
EBIT margin: 9.909796991863235%
Interest burden factor: 0.8614526529681312
Tax burden factor: 0.7247695381134619
ROE archetype: Standard Business
DuPont ROE decomposition for IRISDOREME.NS (quarterly period ending 2026-03-31)
ROE: 4.538256043871549%
Net margin: 10.637499276602428%
Asset turnover: 0.29686647892799484
Equity multiplier (leverage): 1.4371043028570258
EBIT margin: 15.762791735906148%
Interest burden factor: 0.930264027441231
Tax burden factor: 0.7254377952933483
ROE archetype: Low Return
DuPont ROE decomposition for ITRK.L (annual period ending 2022-12-31)
ROE: 23.277693474962067%
Net margin: 9.608819568417427%
Asset turnover: 0.8723055487255142
Equity multiplier (leverage): 2.7771623672230654
EBIT margin: 14.168937329700274%
Interest burden factor: 0.9279398762157381
Tax burden factor: 0.7308242020009529
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ITRK.L (annual period ending 2023-12-31)
ROE: 24.332762085486266%
Net margin: 9.556283233694836%
Asset turnover: 0.9481044746361333
Equity multiplier (leverage): 2.6856301290768223
EBIT margin: 14.606302760837565%
Interest burden factor: 0.8685726038667215
Tax burden factor: 0.7532559791617334
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ITRK.L (annual period ending 2024-12-31)
ROE: 26.022100413939846%
Net margin: 10.821643286573146%
Asset turnover: 0.9449200152209283
Equity multiplier (leverage): 2.5448025185340004
EBIT margin: 15.78745726747613%
Interest burden factor: 0.9146910584282247
Tax burden factor: 0.7493877551020408
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ITRK.L (annual period ending 2025-12-31)
ROE: 29.480130639510634%
Net margin: 10.583984147336519%
Asset turnover: 0.9678949040330482
Equity multiplier (leverage): 2.8777430898334333
EBIT margin: 15.80312390721529%
Interest burden factor: 0.9098285082057902
Tax burden factor: 0.7361167409809485
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ITSA4.SA (annual period ending 2022-12-31)
ROE: 18.493499706016856%
Net margin: 166.79236389347162%
Asset turnover: 0.08781315645146269
Equity multiplier (leverage): 1.2626510746717188
EBIT margin: 14.223426820645772%
Interest burden factor: 12.059652029826013
Tax burden factor: 0.9723825226710635
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for ITSA4.SA (annual period ending 2023-12-31)
ROE: 17.76653211064387%
Net margin: 189.3268319111472%
Asset turnover: 0.07606833303007594
Equity multiplier (leverage): 1.2336347608909886
EBIT margin: 9.115535690098877%
Interest burden factor: 20.468053491827636
Tax burden factor: 1.0147368421052632
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for ITSA4.SA (annual period ending 2024-12-31)
ROE: 14.459122516175832%
Net margin: 180.7771706132362%
Asset turnover: 0.06618119183213263
Equity multiplier (leverage): 1.2085476238741102
EBIT margin: 2.392228293867638%
Interest burden factor: 76.26903553299493
Tax burden factor: 0.9908153078202996
ROE archetype: Standard Business
DuPont ROE decomposition for ITSA4.SA (annual period ending 2025-12-31)
ROE: 18.635727170068105%
Net margin: 200.63037943993214%
Asset turnover: 0.07751778240242657
Equity multiplier (leverage): 1.1982524042974174
EBIT margin: -2.49727239665414%
Tax burden factor: 1.0098236622124597
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for IVC.NS (quarterly period ending 2024-09-30)
ROE: 0.7948229828549621%
Net margin: 30.49694454052807%
Asset turnover: 0.023248593035250852
Equity multiplier (leverage): 1.1210304551926682
EBIT margin: 9.195203505130864%
Interest burden factor: 6.79791013584117
Tax burden factor: 0.48788735858337434
ROE archetype: Low Return
DuPont ROE decomposition for IVC.NS (quarterly period ending 2024-12-31)
Net margin: 43.47499589327201%
EBIT margin: -7.265388496468214%
Tax burden factor: 0.8058461471541356
ROE archetype: Standard Business
DuPont ROE decomposition for IVC.NS (quarterly period ending 2025-03-31)
ROE: 5.608201465394317%
Net margin: 167.32137435816207%
Asset turnover: 0.03165217245982323
Equity multiplier (leverage): 1.0589334325541229
EBIT margin: 15.674705315540066%
Interest burden factor: 7.371873684210527
Tax burden factor: 1.448018642693138
ROE archetype: Standard Business
DuPont ROE decomposition for IVC.NS (quarterly period ending 2025-09-30)
Net margin: 49.3225045701288%
EBIT margin: 26.386737555992795%
Interest burden factor: 2.5977047966576765
Tax burden factor: 0.719564332247557
ROE archetype: Standard Business
DuPont ROE decomposition for IVDA (quarterly period ending 2025-03-31)
ROE: -46.66224152456924%
Net margin: -53.82374323195278%
Asset turnover: 0.3256338712437822
Equity multiplier (leverage): 2.6623314776349045
EBIT margin: -56.66435639804256%
ROE archetype: Low Return
DuPont ROE decomposition for IVDA (quarterly period ending 2025-06-30)
ROE: -35.47125141916689%
Net margin: -36.92953825069196%
Asset turnover: 0.3426494966692801
Equity multiplier (leverage): 2.803189998000908
EBIT margin: -34.8424347816981%
ROE archetype: Low Return
DuPont ROE decomposition for IVDA (quarterly period ending 2025-09-30)
ROE: -8.432557619371593%
Net margin: -13.397853355184417%
Asset turnover: 0.3248912349288166
Equity multiplier (leverage): 1.9372519313465804
EBIT margin: -12.974009360771092%
ROE archetype: Low Return
DuPont ROE decomposition for IVDA (quarterly period ending 2025-12-31)
ROE: -37.87754427817301%
Net margin: -258.59079742253715%
Asset turnover: 0.1025779669280345
Equity multiplier (leverage): 1.4279554618832653
EBIT margin: -262.7100098715422%
ROE archetype: Low Return
DuPont ROE decomposition for IVDA (quarterly period ending 2026-03-31)
ROE: -10.011836692167368%
Net margin: -35.660572329594814%
Asset turnover: 0.20917606198562103
Equity multiplier (leverage): 1.3421883515637558
EBIT margin: -37.860516914362044%
ROE archetype: Low Return
DuPont ROE decomposition for IXIGO.NS (annual period ending 2023-03-31)
ROE: 6.043619662171064%
Net margin: 4.667531172069825%
Asset turnover: 0.8554849170115629
Equity multiplier (leverage): 1.5135526801836128
EBIT margin: 4.49715710723192%
Interest burden factor: 0.9171324638452667
Tax burden factor: 1.1316629583051174
ROE archetype: Standard Business
DuPont ROE decomposition for IXIGO.NS (annual period ending 2024-03-31)
ROE: 18.064052171607614%
Net margin: 11.556658072523186%
Asset turnover: 1.068839091388325
Equity multiplier (leverage): 1.4624148409566098
EBIT margin: 4.727592079564183%
Interest burden factor: 1.9693940078046894
Tax burden factor: 1.2412511258495045
ROE archetype: Balanced Compounder
DuPont ROE decomposition for IXIGO.NS (annual period ending 2025-03-31)
ROE: 11.018697266216936%
Net margin: 6.590348768274621%
Asset turnover: 1.1766964328467548
Equity multiplier (leverage): 1.420880047428054
EBIT margin: 7.714116331928168%
Interest burden factor: 1.1587641437200464
Tax burden factor: 0.7372710252927573
ROE archetype: Standard Business
DuPont ROE decomposition for IXIGO.NS (annual period ending 2026-03-31)
ROE: 5.2467511583440904%
Net margin: 5.873836254386057%
Asset turnover: 0.6937754259080662
Equity multiplier (leverage): 1.2875073556368273
EBIT margin: 4.72175557942378%
Interest burden factor: 1.5269466241269294
Tax burden factor: 0.8146939236503274
ROE archetype: Standard Business
DuPont ROE decomposition for IZZ.V (quarterly period ending 2024-12-31)
ROE: -87.4368309346388%
Asset turnover: 0
Equity multiplier (leverage): 1.2899626640226804
ROE archetype: Low Return
DuPont ROE decomposition for IZZ.V (quarterly period ending 2025-03-31)
ROE: -34.619550599370456%
Asset turnover: 0
Equity multiplier (leverage): 1.517085147679938
ROE archetype: Low Return
DuPont ROE decomposition for IZZ.V (quarterly period ending 2025-06-30)
ROE: -62.12839356171153%
Asset turnover: 0
Equity multiplier (leverage): 2.241507398791607
ROE archetype: Low Return
DuPont ROE decomposition for IZZ.V (quarterly period ending 2025-09-30)
ROE: -32.577100010326035%
Asset turnover: 0
Equity multiplier (leverage): 3.2888786550113815
ROE archetype: Low Return
DuPont ROE decomposition for IZZ.V (quarterly period ending 2025-12-31)
ROE: -53.08282890383612%
Asset turnover: 0
Equity multiplier (leverage): 1.4500466008676525
ROE archetype: Low Return
DuPont ROE decomposition for IZZ.V (quarterly period ending 2026-03-31)
ROE: -9.309608616644049%
Asset turnover: 0
Equity multiplier (leverage): 1.1487152160080116
ROE archetype: Low Return
DuPont ROE decomposition for JACK (quarterly period ending 2025-03-31)
Net margin: -53.523299878448505%
Asset turnover: 0.10301471888054634
EBIT margin: 19.341740331387758%
Interest burden factor: 0.5562776037511917
Tax burden factor: -4.974572417893743
ROE archetype: Standard Business
DuPont ROE decomposition for JACK (quarterly period ending 2025-06-30)
Net margin: 6.614972956902221%
Asset turnover: 0.1286748389328073
EBIT margin: 16.047473324784452%
Interest burden factor: 0.40274346882251666
Tax burden factor: 1.0235119185911434
ROE archetype: Standard Business
DuPont ROE decomposition for JACK (quarterly period ending 2025-09-30)
Net margin: 1.7768621644241294%
Asset turnover: 0.12571239839121676
EBIT margin: 11.953659336650388%
Interest burden factor: 0.11397209684037751
Tax burden factor: 1.3042304230423043
ROE archetype: Standard Business
DuPont ROE decomposition for JACK (quarterly period ending 2026-01-31)
Net margin: -0.7032562078525508%
Asset turnover: 0.15146841376297712
EBIT margin: 15.638152078439676%
Interest burden factor: 0.3891836510666325
Tax burden factor: -0.11555095900714554
ROE archetype: Standard Business
DuPont ROE decomposition for JACK (quarterly period ending 2026-03-31)
Net margin: 4.029276657332536%
Asset turnover: 0.12627958125662248
EBIT margin: 14.882956297391686%
Interest burden factor: 0.45806247027112734
Tax burden factor: 0.5910349601938387
ROE archetype: Standard Business
DuPont ROE decomposition for JAGSNPHARM.NS (annual period ending 2023-03-31)
ROE: 16.81729498395116%
Net margin: 11.288305719137863%
Asset turnover: 1.214254203728212
Equity multiplier (leverage): 1.2269242872427464
EBIT margin: 14.502733256165667%
Interest burden factor: 1.013923681910865
Tax burden factor: 0.7676683521029649
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JAGSNPHARM.NS (annual period ending 2024-03-31)
ROE: 12.880582774246353%
Net margin: 10.763193452865808%
Asset turnover: 1.0055817250938497
Equity multiplier (leverage): 1.1900822960870658
EBIT margin: 10.353039261722456%
Interest burden factor: 1.3823760818253341
Tax burden factor: 0.7520506210452309
ROE archetype: Standard Business
DuPont ROE decomposition for JAGSNPHARM.NS (annual period ending 2025-03-31)
ROE: 25.61924560620687%
Net margin: 20.602085473138924%
Asset turnover: 1.072858170264232
Equity multiplier (leverage): 1.159078472271486
EBIT margin: 15.97969603596362%
Interest burden factor: 1.626897997205403
Tax burden factor: 0.7924691163629597
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for JAGSNPHARM.NS (annual period ending 2026-03-31)
ROE: 15.93083168701861%
Net margin: 14.999390721559752%
Asset turnover: 0.9211416583927741
Equity multiplier (leverage): 1.153024159793654
EBIT margin: 16.93097745669771%
Interest burden factor: 1.1827678387826444
Tax burden factor: 0.7490176988073298
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JAIPURKURT.NS (quarterly period ending 2024-12-31)
Net margin: 4.936891829466374%
EBIT margin: 11.06516458789694%
Interest burden factor: 0.5331627499831662
Tax burden factor: 0.8368274816872948
ROE archetype: Standard Business
DuPont ROE decomposition for JAIPURKURT.NS (quarterly period ending 2025-03-31)
ROE: 1.3084648493543758%
Net margin: 3.45852800194163%
Asset turnover: 0.21332970901936416
Equity multiplier (leverage): 1.7734519368723098
EBIT margin: 12.017879173998342%
Interest burden factor: 0.37449511948838776
Tax burden factor: 0.7684529828109201
ROE archetype: Low Return
DuPont ROE decomposition for JAIPURKURT.NS (quarterly period ending 2025-12-31)
Net margin: 0.8643023048061461%
EBIT margin: 4.774134953248764%
Interest burden factor: 0.27935443630126305
Tax burden factor: 0.6480602846776444
ROE archetype: Standard Business
DuPont ROE decomposition for JAT.AX (annual period ending 2021-06-30)
ROE: -154.5193122419161%
Net margin: -73.15947361074825%
Asset turnover: 0.7348064146053713
Equity multiplier (leverage): 2.874347391870464
EBIT margin: -27.85150297230265%
ROE archetype: Low Return
DuPont ROE decomposition for JAT.AX (annual period ending 2022-06-30)
ROE: -73.50444789660737%
Net margin: -18.41691667294704%
Asset turnover: 1.2388924075051415
Equity multiplier (leverage): 3.221536863988502
EBIT margin: -11.397420264328167%
ROE archetype: Low Return
DuPont ROE decomposition for JAT.AX (annual period ending 2023-06-30)
ROE: -47.30050039341726%
Net margin: -7.802492678242258%
Asset turnover: 1.9929784564513666
Equity multiplier (leverage): 3.041793736293229
EBIT margin: -4.053105308711021%
ROE archetype: Low Return
DuPont ROE decomposition for JAT.AX (annual period ending 2024-06-30)
ROE: 20.94237795890717%
Net margin: 4.231169882532856%
Asset turnover: 2.0374927237789175
Equity multiplier (leverage): 2.4292346328188907
EBIT margin: 3.602068017093963%
Interest burden factor: 1.0719533234546994
Tax burden factor: 1.0958034877216853
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JAYKAY.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.2959689537859258
ROE archetype: Standard Business
DuPont ROE decomposition for JAYKAY.NS (quarterly period ending 2025-03-31)
ROE: -0.784706747617873%
Net margin: -34.628720550395094%
Asset turnover: 0.018054224615087076
Equity multiplier (leverage): 1.2551397971477953
EBIT margin: -56.820628866543785%
ROE archetype: Low Return
DuPont ROE decomposition for JAYKAY.NS (quarterly period ending 2025-06-30)
Net margin: 36.454867591766074%
EBIT margin: 5.338887536404375%
Interest burden factor: 7.987603864081605
Tax burden factor: 0.8548466895860557
ROE archetype: Standard Business
DuPont ROE decomposition for JAYKAY.NS (quarterly period ending 2025-09-30)
ROE: 1.7482938394859815%
Net margin: 13.909167596914958%
Asset turnover: 0.09628387327260526
Equity multiplier (leverage): 1.3054484727765703
EBIT margin: 11.057850872742035%
Interest burden factor: 1.5280984269469577
Tax burden factor: 0.8231501900248676
ROE archetype: Low Return
DuPont ROE decomposition for JAYKAY.NS (quarterly period ending 2025-12-31)
Net margin: 11.305254030980608%
EBIT margin: 13.439214313107565%
Interest burden factor: 1.085001054603655
Tax burden factor: 0.7753116066323613
ROE archetype: Standard Business
DuPont ROE decomposition for JAYKAY.NS (quarterly period ending 2026-03-31)
ROE: 28.291092805734337%
Net margin: 322.3255266372233%
Asset turnover: 0.07336947687046763
Equity multiplier (leverage): 1.196298614926326
EBIT margin: -15.689480663670002%
Tax burden factor: 1.1018692576127767
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for JBH.AX (annual period ending 2022-06-30)
ROE: 42.56033742091698%
Net margin: 5.902296360485269%
Asset turnover: 2.9202252166761564
Equity multiplier (leverage): 2.4692650160118723
EBIT margin: 6.256499133448873%
Interest burden factor: 1.3422783933518005
Tax burden factor: 0.702824713014317
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JBH.AX (annual period ending 2023-06-30)
ROE: 38.112841407600264%
Net margin: 5.449596941743538%
Asset turnover: 2.9496638902386954
Equity multiplier (leverage): 2.37101561174976
EBIT margin: 5.64593202027757%
Interest burden factor: 1.3746090156393744
Tax burden factor: 0.7021817695087672
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JBH.AX (annual period ending 2024-06-30)
ROE: 29.55580074319063%
Net margin: 4.57445477669822%
Asset turnover: 2.8633701541032046
Equity multiplier (leverage): 2.2564509513585054
EBIT margin: 4.276302072474043%
Interest burden factor: 1.5294978059483177
Tax burden factor: 0.6993943257889703
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JBH.AX (annual period ending 2025-06-30)
ROE: 28.81620083173468%
Net margin: 4.384734907340736%
Asset turnover: 2.8376810316180925
Equity multiplier (leverage): 2.315953328713277
EBIT margin: 4.14598097548035%
Interest burden factor: 1.526508226691042
Tax burden factor: 0.692814371257485
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JBIO (quarterly period ending 2025-06-30)
ROE: -15.942963742086565%
Asset turnover: 0
Equity multiplier (leverage): 1.111194903649606
ROE archetype: Low Return
DuPont ROE decomposition for JBIO (quarterly period ending 2025-09-30)
ROE: -13.218623162913296%
Asset turnover: 0
Equity multiplier (leverage): 1.1194953032538553
ROE archetype: Low Return
DuPont ROE decomposition for JBIO (quarterly period ending 2025-12-31)
ROE: -12.476751637153619%
Asset turnover: 0
Equity multiplier (leverage): 1.0788627447915853
ROE archetype: Low Return
DuPont ROE decomposition for JBIO (quarterly period ending 2026-03-31)
ROE: -12.836020223218544%
Asset turnover: 0
Equity multiplier (leverage): 1.0639670577760818
ROE archetype: Low Return
DuPont ROE decomposition for JBTM (annual period ending 2022-12-31)
ROE: 15.17561298873426%
Net margin: 8.639879268062629%
Asset turnover: 0.602158273381295
Equity multiplier (leverage): 2.9169427877181358
EBIT margin: 8.784506068037476%
Interest burden factor: 0.8589835361488904
Tax burden factor: 1.145
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for JBTM (annual period ending 2023-12-31)
ROE: 48.66558075429144%
Net margin: 35.00360490266763%
Asset turnover: 0.6220428299136674
Equity multiplier (leverage): 2.235058263375517
EBIT margin: 10.580389329488103%
Interest burden factor: 0.8693923906871096
Tax burden factor: 3.805355976485957
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JBTM (annual period ending 2024-12-31)
ROE: 5.6312024001846295%
Net margin: 4.976689976689977%
Asset turnover: 0.560399725678456
Equity multiplier (leverage): 2.0191223500708846
EBIT margin: 6.981351981351981%
Interest burden factor: 0.7963272120200334
Tax burden factor: 0.8951781970649895
ROE archetype: Standard Business
DuPont ROE decomposition for JBTM (annual period ending 2025-12-31)
ROE: -1.681091877496671%
Net margin: -1.3295771681322732%
Asset turnover: 0.6546081261579559
Equity multiplier (leverage): 1.9315079893475366
EBIT margin: 5.757990627139171%
Interest burden factor: -0.28532235939643347
ROE archetype: Low Return
DuPont ROE decomposition for JCE (annual period ending 2022-12-31)
ROE: -24.502649948473998%
Asset turnover: -0.24272629463083797
Equity multiplier (leverage): 1.0050402934794713
ROE archetype: Low Return
DuPont ROE decomposition for JCE (annual period ending 2023-12-31)
ROE: 19.909581711779676%
Net margin: 99.4628248784569%
Asset turnover: 0.1992995999943983
Equity multiplier (leverage): 1.0043727453545133
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for JCE (annual period ending 2024-12-31)
ROE: 23.931661059214353%
Net margin: 99.61601182159436%
Asset turnover: 0.23966109254881784
Equity multiplier (leverage): 1.00241177148273
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for JCE (annual period ending 2025-12-31)
ROE: 17.063780805304983%
Net margin: 99.50440396517811%
Asset turnover: 0.17110926352006334
Equity multiplier (leverage): 1.0022116321360477
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for JDG.L (annual period ending 2022-12-31)
ROE: 23.486238532110097%
Net margin: 11.307420494699647%
Asset turnover: 0.6021276595744681
Equity multiplier (leverage): 3.44954128440367
EBIT margin: 18.639575971731446%
Interest burden factor: 0.7582938388625593
Tax burden factor: 0.7999999999999999
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for JDG.L (annual period ending 2023-12-31)
ROE: 14.724091279689643%
Net margin: 7.274063188831742%
Asset turnover: 0.7510213579323527
Equity multiplier (leverage): 2.695250553250965
EBIT margin: 16.091109478324764%
Interest burden factor: 0.6118721461187214
Tax burden factor: 0.7388059701492538
ROE archetype: Standard Business
DuPont ROE decomposition for JDG.L (annual period ending 2024-12-31)
ROE: 12.64299685851461%
Net margin: 8.08383233532934%
Asset turnover: 0.6805514359774577
Equity multiplier (leverage): 2.2981151087665226
EBIT margin: 12.874251497005988%
Interest burden factor: 0.7558139534883721
Tax burden factor: 0.8307692307692308
ROE archetype: Standard Business
DuPont ROE decomposition for JDG.L (annual period ending 2025-12-31)
ROE: 7.3010464833292765%
Net margin: 4.115226337448559%
Asset turnover: 0.7686022298953584
Equity multiplier (leverage): 2.308286687758579
EBIT margin: 8.779149519890261%
Interest burden factor: 0.6953125
Tax burden factor: 0.6741573033707865
ROE archetype: Standard Business
DuPont ROE decomposition for JEM (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 3.151094273142314
ROE archetype: Standard Business
DuPont ROE decomposition for JEM (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 2.963849839520759
ROE archetype: Standard Business
DuPont ROE decomposition for JEM (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.7936835137353382
ROE archetype: Standard Business
DuPont ROE decomposition for JFB (annual period ending 2022-12-31)
ROE: 93.11256423678006%
Net margin: 10.197331604286004%
Asset turnover: 2.9351790285813206
Equity multiplier (leverage): 3.1109078647292385
EBIT margin: 10.180150519036577%
Interest burden factor: 1.0016877044418253
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for JFB (annual period ending 2023-12-31)
ROE: 88.77549698448985%
Net margin: 12.809002087777104%
Asset turnover: 3.701835934774677
Equity multiplier (leverage): 1.8722362463153965
EBIT margin: 12.425766629262192%
Interest burden factor: 1.0308419971136755
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JFB (annual period ending 2024-12-31)
ROE: 1.8280519061978417%
Net margin: 0.515443489085293%
Asset turnover: 2.5359713366150203
Equity multiplier (leverage): 1.3985021049747728
EBIT margin: -0.14511506792415158%
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for JFB (annual period ending 2025-12-31)
ROE: -23.876821518375905%
Net margin: -17.263594912656878%
Asset turnover: 1.2466215661872122
Equity multiplier (leverage): 1.1094574235557952
EBIT margin: -18.514406801276547%
ROE archetype: Low Return
DuPont ROE decomposition for JFIN (annual period ending 2022-12-31)
ROE: 95.06477229616037%
Net margin: 36.077121391545056%
Asset turnover: 1.0829376967562325
Equity multiplier (leverage): 2.4332361661631103
EBIT margin: 36.131746089000046%
Interest burden factor: 1.123239135749933
Tax burden factor: 0.8889364234120917
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JFIN (annual period ending 2023-12-31)
ROE: 71.12734391519338%
Net margin: 23.736037036163086%
Asset turnover: 1.252327385954941
Equity multiplier (leverage): 2.392822603073959
EBIT margin: 24.373531267325944%
Interest burden factor: 1.1611383370732549
Tax burden factor: 0.8386983561080725
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JFIN (annual period ending 2024-12-31)
ROE: 37.92308623174245%
Net margin: 18.211897469277883%
Asset turnover: 1.0353897826420753
Equity multiplier (leverage): 2.0111506420756298
EBIT margin: 21.513672050076607%
Interest burden factor: 1.0379426529328573
Tax burden factor: 0.8155813637514591
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JFIN (annual period ending 2025-12-31)
ROE: 41.33612444768106%
Net margin: 24.68169567306688%
Asset turnover: 0.8924839520667288
Equity multiplier (leverage): 1.876524967656574
EBIT margin: 28.885794230005835%
Interest burden factor: 1.0423161257621727
Tax burden factor: 0.819768493929438
ROE archetype: Balanced Compounder
DuPont ROE decomposition for JFR (quarterly period ending 2025-01-31)
Equity multiplier (leverage): 1.6954876692624632
ROE archetype: Standard Business
DuPont ROE decomposition for JFR (quarterly period ending 2026-01-31)
Equity multiplier (leverage): 1.7116030677427305
ROE archetype: Standard Business
DuPont ROE decomposition for JG.V (quarterly period ending 2025-03-31)
ROE: -5.8875681232462185%
Asset turnover: 0
Equity multiplier (leverage): 1.0424923449277121
ROE archetype: Low Return
DuPont ROE decomposition for JG.V (quarterly period ending 2025-06-30)
ROE: -4.898809977726161%
Asset turnover: 0
Equity multiplier (leverage): 1.052365691661955
ROE archetype: Low Return
DuPont ROE decomposition for JG.V (quarterly period ending 2025-09-30)
ROE: -4.679883445314805%
Asset turnover: 0
Equity multiplier (leverage): 1.0402897721355981
ROE archetype: Low Return
DuPont ROE decomposition for JG.V (quarterly period ending 2025-12-31)
ROE: -4.172221357057296%
Asset turnover: 0
Equity multiplier (leverage): 1.0231131859902591
ROE archetype: Low Return
DuPont ROE decomposition for JG.V (quarterly period ending 2026-03-31)
ROE: -3.6454651169393926%
Asset turnover: 0
Equity multiplier (leverage): 1.0230707164783492
ROE archetype: Low Return
DuPont ROE decomposition for JJJJ.V (quarterly period ending 2024-10-31)
ROE: -8.922657716554621%
Asset turnover: 0
Equity multiplier (leverage): 1.445367596338965
ROE archetype: Low Return
DuPont ROE decomposition for JJJJ.V (quarterly period ending 2025-01-31)
ROE: -5.080827219385994%
Asset turnover: 0
Equity multiplier (leverage): 1.4747781318420954
ROE archetype: Low Return
DuPont ROE decomposition for JJJJ.V (quarterly period ending 2025-04-30)
ROE: -9.249225695371415%
Asset turnover: 0
Equity multiplier (leverage): 1.533759826134645
ROE archetype: Low Return
DuPont ROE decomposition for JJJJ.V (quarterly period ending 2025-10-31)
ROE: -8.918169163681464%
Asset turnover: 0
Equity multiplier (leverage): 1.3313179397789277
ROE archetype: Low Return
DuPont ROE decomposition for JJJJ.V (quarterly period ending 2026-01-31)
ROE: -10.260456800031639%
Asset turnover: 0
Equity multiplier (leverage): 1.0500766484171886
ROE archetype: Low Return
DuPont ROE decomposition for JLHL.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.1082386151408177
ROE archetype: Standard Business
DuPont ROE decomposition for JLHL.NS (quarterly period ending 2025-03-31)
ROE: 3.4279196801456164%
Net margin: 13.450325401516661%
Asset turnover: 0.2003603571433885
Equity multiplier (leverage): 1.271996888466913
EBIT margin: 18.431003294114852%
Interest burden factor: 1.020515713134569
Tax burden factor: 0.7150956208644568
ROE archetype: Low Return
DuPont ROE decomposition for JLHL.NS (quarterly period ending 2025-06-30)
Net margin: 12.62135922330097%
EBIT margin: 16.373966199208915%
Interest burden factor: 1.0810260014054813
Tax burden factor: 0.713043619580056
ROE archetype: Standard Business
DuPont ROE decomposition for JLHL.NS (quarterly period ending 2025-09-30)
ROE: 3.9614012017153177%
Net margin: 14.60182049594923%
Asset turnover: 0.19459870188103165
Equity multiplier (leverage): 1.3941255446521736
EBIT margin: 17.982923006180947%
Interest burden factor: 1.048540671884271
Tax burden factor: 0.7743930371049015
ROE archetype: Low Return
DuPont ROE decomposition for JLHL.NS (quarterly period ending 2025-12-31)
Net margin: 11.646919398851017%
EBIT margin: 16.893972362035978%
Interest burden factor: 0.921992709599028
Tax burden factor: 0.7477420488490598
ROE archetype: Standard Business
DuPont ROE decomposition for JLHL.NS (quarterly period ending 2026-03-31)
ROE: 3.277976132266644%
Net margin: 13.050552034612389%
Asset turnover: 0.16274318343656596
Equity multiplier (leverage): 1.5433843686876372
EBIT margin: 16.993177563828198%
Interest burden factor: 1.0250356568445969
Tax burden factor: 0.7492302682219195
ROE archetype: Low Return
DuPont ROE decomposition for JMG (annual period ending 2023-09-30)
Net margin: -22.067839339268033%
Asset turnover: 2.341689255700788
EBIT margin: -11.014620433180157%
ROE archetype: Standard Business
DuPont ROE decomposition for JMG (annual period ending 2024-09-30)
Net margin: 3.1768686364668306%
Asset turnover: 3.3871068554399892
EBIT margin: 3.7208207451012396%
Interest burden factor: 1.0434324104447215
Tax burden factor: 0.8182691668487709
ROE archetype: Standard Business
DuPont ROE decomposition for JMG (annual period ending 2025-09-30)
Net margin: 6.9248793134667235%
Asset turnover: 2.7552649649736356
EBIT margin: 10.308575725811%
Interest burden factor: 0.7282458204927472
Tax burden factor: 0.9224345103971384
ROE archetype: Standard Business
DuPont ROE decomposition for JMSB (quarterly period ending 2025-03-31)
ROE: 1.9015014350208335%
Net margin: 32.93392673741869%
Asset turnover: 0.00642703500038725
Equity multiplier (leverage): 8.983435985420504
Tax burden factor: 0.7778137128072445
ROE archetype: Low Return
DuPont ROE decomposition for JMSB (quarterly period ending 2025-06-30)
ROE: 2.0142493437802207%
Net margin: 33.0655089742759%
Asset turnover: 0.006798101923074805
Equity multiplier (leverage): 8.960873512404033
Tax burden factor: 0.7751784900501291
ROE archetype: Low Return
DuPont ROE decomposition for JMSB (quarterly period ending 2025-09-30)
ROE: 2.1050827386331767%
Net margin: 33.24924629299206%
Asset turnover: 0.0070780666813718114
Equity multiplier (leverage): 8.944842858923618
Tax burden factor: 0.7874107533148769
ROE archetype: Low Return
DuPont ROE decomposition for JMSB (quarterly period ending 2025-12-31)
ROE: 2.252298555193878%
Net margin: 36.18127331661672%
Asset turnover: 0.00702197550661421
Equity multiplier (leverage): 8.86508290027221
Tax burden factor: 0.7629610523600722
ROE archetype: Low Return
DuPont ROE decomposition for JMSB (quarterly period ending 2026-03-31)
ROE: 2.2859390953286436%
Net margin: 36.330613946287144%
Asset turnover: 0.007168989732971889
Equity multiplier (leverage): 8.7767546858754
Tax burden factor: 0.7774945839174207
ROE archetype: Low Return
DuPont ROE decomposition for JMT.LS (quarterly period ending 2024-12-31)
ROE: 4.949277589916998%
Net margin: 1.8507874468329693%
Asset turnover: 0.5687479568486433
Equity multiplier (leverage): 4.701813710421148
EBIT margin: 3.3911943901597885%
Interest burden factor: 0.7322033898305085
Tax burden factor: 0.7453703703703705
ROE archetype: Low Return
DuPont ROE decomposition for JMT.LS (quarterly period ending 2025-03-31)
ROE: 3.905013868692627%
Net margin: 1.5160558672555808%
Asset turnover: 0.5566906687969077
Equity multiplier (leverage): 4.626935371251769
EBIT margin: 2.9724244956428314%
Interest burden factor: 0.678714859437751
Tax burden factor: 0.7514792899408285
ROE archetype: Low Return
DuPont ROE decomposition for JMT.LS (quarterly period ending 2025-06-30)
ROE: 4.567016876370131%
Net margin: 1.5853658536585367%
Asset turnover: 0.6102352506013446
Equity multiplier (leverage): 4.720693731113236
EBIT margin: 3.1707317073170733%
Interest burden factor: 0.6958041958041958
Tax burden factor: 0.7185929648241206
ROE archetype: Low Return
DuPont ROE decomposition for JMT.LS (quarterly period ending 2025-09-30)
ROE: 6.878470080197409%
Net margin: 2.44035894068724%
Asset turnover: 0.5921078209032593
Equity multiplier (leverage): 4.760333127698951
EBIT margin: 4.05996935872182%
Interest burden factor: 0.77088948787062
Tax burden factor: 0.7797202797202798
ROE archetype: Standard Business
DuPont ROE decomposition for JMT.LS (quarterly period ending 2025-12-31)
ROE: 4.825581395348837%
Net margin: 1.7553135243734797%
Asset turnover: 0.5797394636015326
Equity multiplier (leverage): 4.7420058139534875
EBIT margin: 3.4048852701702446%
Interest burden factor: 0.7111801242236024
Tax burden factor: 0.7248908296943231
ROE archetype: Low Return
DuPont ROE decomposition for JMT.LS (quarterly period ending 2026-03-31)
ROE: 3.2945575472727473%
Net margin: 1.3364779874213837%
Asset turnover: 0.5180002060119205
Equity multiplier (leverage): 4.758886592632764
EBIT margin: 2.976190476190476%
Interest burden factor: 0.6000000000000001
Tax burden factor: 0.7484276729559748
ROE archetype: Low Return
DuPont ROE decomposition for JNH.V (annual period ending 2022-01-31)
ROE: -191.24448627029867%
Net margin: -81.00125387829765%
Asset turnover: 1.1842194723500326
Equity multiplier (leverage): 1.9937237540587518
EBIT margin: -72.04266381599382%
ROE archetype: Low Return
DuPont ROE decomposition for JNH.V (annual period ending 2023-01-31)
ROE: -331.17349154852207%
Net margin: -45.69445725927396%
Asset turnover: 2.062141505001082
Equity multiplier (leverage): 3.514581187742275
EBIT margin: -34.25515307341652%
ROE archetype: Low Return
DuPont ROE decomposition for JNS.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.444279002542433
ROE archetype: Standard Business
DuPont ROE decomposition for JOB (quarterly period ending 2025-03-31)
ROE: -65.39957741750754%
Net margin: -135.20718513982445%
Asset turnover: 0.39655172413793105
Equity multiplier (leverage): 1.219762642917794
EBIT margin: -4.980608287405593%
ROE archetype: Low Return
DuPont ROE decomposition for JOB (quarterly period ending 2025-06-30)
ROE: -0.8373253097905696%
Net margin: -1.7249113077519065%
Asset turnover: 0.40091879608285513
Equity multiplier (leverage): 1.2107961518666615
EBIT margin: -2.218325653468173%
ROE archetype: Low Return
DuPont ROE decomposition for JOB (quarterly period ending 2025-09-30)
ROE: -1.0218614610826156%
Net margin: -2.1866075614850176%
Asset turnover: 0.38919716989739633
Equity multiplier (leverage): 1.2007469747522534
EBIT margin: -3.2948297174033505%
ROE archetype: Low Return
DuPont ROE decomposition for JOB (quarterly period ending 2025-12-31)
ROE: -0.30005100867147416%
Net margin: -0.7311366738155586%
Asset turnover: 0.3449806625189171
Equity multiplier (leverage): 1.1896022323795046
EBIT margin: -1.9935659972704232%
ROE archetype: Low Return
DuPont ROE decomposition for JOB (quarterly period ending 2026-03-31)
ROE: 0.027994681010607987%
Net margin: 0.07186489399928135%
Asset turnover: 0.32849663173337157
Equity multiplier (leverage): 1.1858446895089934
EBIT margin: -0.29259278271135974%
ROE archetype: Low Return
DuPont ROE decomposition for JOYY (quarterly period ending 2024-12-31)
Asset turnover: 0.0729889501536771
Equity multiplier (leverage): 1.58155036453534
EBIT margin: 4.928964811828642%
ROE archetype: Standard Business
DuPont ROE decomposition for JOYY (quarterly period ending 2025-03-31)
ROE: 33.95027103770442%
Net margin: 388.65563132268363%
Asset turnover: 0.06590885698828561
Equity multiplier (leverage): 1.3253619586471552
EBIT margin: 2.4692981302758565%
Interest burden factor: 4.213320226099779
Tax burden factor: 37.35656789547363
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for JOYY (quarterly period ending 2025-06-30)
ROE: 0.9391237192361885%
Net margin: 11.979084606900898%
Asset turnover: 0.06878995768593779
Equity multiplier (leverage): 1.1396569280712439
EBIT margin: 1.1414841657475974%
Interest burden factor: 11.26086956521739
Tax burden factor: 0.9319268247839676
ROE archetype: Low Return
DuPont ROE decomposition for JOYY (quarterly period ending 2025-09-30)
ROE: 0.931850262956032%
Net margin: 11.469380124060338%
Asset turnover: 0.07143365621258639
Equity multiplier (leverage): 1.1373740261420382
EBIT margin: 3.6192595252683626%
Interest burden factor: 3.0040405073649756
Tax burden factor: 1.0549076359921683
ROE archetype: Low Return
DuPont ROE decomposition for JOYY (quarterly period ending 2025-12-31)
ROE: 0.8262533120620082%
Net margin: 9.335883529581588%
Asset turnover: 0.07737161599459262
Equity multiplier (leverage): 1.1438685531754489
EBIT margin: 3.138769169433389%
Interest burden factor: 2.227484259512729
Tax burden factor: 1.3353078530170825
ROE archetype: Low Return
DuPont ROE decomposition for JOYY (quarterly period ending 2026-03-31)
ROE: 0.76848293571692%
Net margin: 9.117689400755804%
Asset turnover: 0.07316359566206991
Equity multiplier (leverage): 1.1520050788930596
EBIT margin: 1.2737088357027173%
Interest burden factor: 3.5387115004238483
Tax burden factor: 2.022876991256438
ROE archetype: Low Return
DuPont ROE decomposition for JUBLPHARMA.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.0118778471402057
ROE archetype: Standard Business
DuPont ROE decomposition for JUBLPHARMA.NS (quarterly period ending 2024-12-31)
Net margin: 5.563213320835861%
EBIT margin: 10.81215195456801%
Interest burden factor: 0.6654767975522692
Tax burden factor: 0.7731800766283525
ROE archetype: Standard Business
DuPont ROE decomposition for JUBLPHARMA.NS (quarterly period ending 2025-03-31)
ROE: 2.46209085371718%
Net margin: 8.017538365173818%
Asset turnover: 0.15018343733341696
Equity multiplier (leverage): 2.044753630622255
EBIT margin: 13.059818352646413%
Interest burden factor: 0.8233413269384493
Tax burden factor: 0.7456310679611651
ROE archetype: Low Return
DuPont ROE decomposition for JUBLPHARMA.NS (quarterly period ending 2025-06-30)
Net margin: 5.476608653999681%
EBIT margin: 10.192133695247218%
Interest burden factor: 0.806266318537859
Tax burden factor: 0.6664507772020726
ROE archetype: Standard Business
DuPont ROE decomposition for JUBLPHARMA.NS (quarterly period ending 2025-12-31)
Net margin: 2.6416520958366805%
EBIT margin: 7.976938708000566%
Interest burden factor: 0.5533175355450237
Tax burden factor: 0.5985010706638115
ROE archetype: Standard Business
DuPont ROE decomposition for JUBLPHARMA.NS (quarterly period ending 2026-03-31)
ROE: 1.6827329612717739%
Net margin: 5.2548191180353845%
Asset turnover: 0.1463791737262203
Equity multiplier (leverage): 2.187651502339478
EBIT margin: 9.792271807059238%
Interest burden factor: 0.7910112359550561
Tax burden factor: 0.678409090909091
ROE archetype: Low Return
DuPont ROE decomposition for JUN3.DE (annual period ending 2021-12-31)
ROE: 14.83383251720145%
Net margin: 6.306784612064442%
Asset turnover: 0.7349133388431127
Equity multiplier (leverage): 3.200436700360421
EBIT margin: 8.409093321288783%
Interest burden factor: 0.9792527978010266
Tax burden factor: 0.7658857799176819
ROE archetype: Standard Business
DuPont ROE decomposition for JUN3.DE (annual period ending 2022-12-31)
ROE: 13.556816387978612%
Net margin: 5.659423919665676%
Asset turnover: 0.7728474116021924
Equity multiplier (leverage): 3.0995006466527006
EBIT margin: 7.879148337264086%
Interest burden factor: 0.9256448720647363
Tax burden factor: 0.7759764652375785
ROE archetype: Standard Business
DuPont ROE decomposition for JUN3.DE (annual period ending 2023-12-31)
ROE: 14.29744212202495%
Net margin: 5.396341468912006%
Asset turnover: 0.8657550523714891
Equity multiplier (leverage): 3.0602992042865886
EBIT margin: 7.603364439268236%
Interest burden factor: 0.946532155172005
Tax burden factor: 0.7498221122046062
ROE archetype: Standard Business
DuPont ROE decomposition for JUN3.DE (annual period ending 2024-12-31)
ROE: 12.024863256361822%
Net margin: 5.359891689385931%
Asset turnover: 0.743766043500306
Equity multiplier (leverage): 3.0163920383921297
EBIT margin: 7.928559505925555%
Interest burden factor: 0.9445614035087719
Tax burden factor: 0.7157008420009906
ROE archetype: Standard Business
DuPont ROE decomposition for JUN3.DE (annual period ending 2025-12-31)
ROE: 4.492101356830869%
Net margin: 1.8829174315261445%
Asset turnover: 0.8008643607948215
Equity multiplier (leverage): 2.9789231756992205
EBIT margin: 6.203086094400319%
Interest burden factor: 0.5754468209786112
Tax burden factor: 0.5274949083503055
ROE archetype: Low Return
DuPont ROE decomposition for JUSTDIAL.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.1986849601875056
ROE archetype: Standard Business
DuPont ROE decomposition for JUSTDIAL.NS (quarterly period ending 2024-12-31)
Net margin: 45.70006612605715%
EBIT margin: 25.9596979083284%
Interest burden factor: 1.9998659337712834
Tax burden factor: 0.8802708319367164
ROE archetype: Standard Business
DuPont ROE decomposition for JUSTDIAL.NS (quarterly period ending 2025-03-31)
ROE: 3.421252577879083%
Net margin: 54.49515905947441%
Asset turnover: 0.05238551536877265
Equity multiplier (leverage): 1.1984391620536199
EBIT margin: 25.681189488243433%
Interest burden factor: 2.417261343745792
Tax burden factor: 0.8778477134740712
ROE archetype: Low Return
DuPont ROE decomposition for JUSTDIAL.NS (quarterly period ending 2025-06-30)
Net margin: 53.59900624454442%
EBIT margin: 25.088967971530252%
Interest burden factor: 2.6617155091663323
Tax burden factor: 0.8026243024483435
ROE archetype: Standard Business
DuPont ROE decomposition for JUSTDIAL.NS (quarterly period ending 2025-12-31)
Net margin: 38.57829827603127%
EBIT margin: 27.501717426150673%
Interest burden factor: 1.7321279885809444
Tax burden factor: 0.8098475484136795
ROE archetype: Standard Business
DuPont ROE decomposition for JUSTDIAL.NS (quarterly period ending 2026-03-31)
ROE: 1.958296125706945%
Net margin: 32.54784533263898%
Asset turnover: 0.05083245507654484
Equity multiplier (leverage): 1.1836274694114144
EBIT margin: 25.3515167295925%
Interest burden factor: 1.6008473488252664
Tax burden factor: 0.8019889325527307
ROE archetype: Low Return
DuPont ROE decomposition for JUSTDIAL.NS (quarterly period ending 2026-06-30)
Net margin: 50.758848138760804%
EBIT margin: 23.486120866033534%
Interest burden factor: 2.68612664152906
Tax burden factor: 0.8045887990706229
ROE archetype: Standard Business
DuPont ROE decomposition for JYD (annual period ending 2021-12-31)
ROE: 61.44983038147429%
Net margin: 1.8888252988103336%
Asset turnover: 3.193551567733502
Equity multiplier (leverage): 10.187203087080427
EBIT margin: 2.347492055976613%
Interest burden factor: 0.9312200786960159
Tax burden factor: 0.8640429444596716
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for JYD (annual period ending 2022-12-31)
ROE: 15.8010222650454%
Net margin: 0.5964375985443112%
Asset turnover: 4.178251534648948
Equity multiplier (leverage): 6.340530423491979
EBIT margin: 0.10770200222505018%
Interest burden factor: 5.6395170661684295
Tax burden factor: 0.9819724886707806
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for JYD (annual period ending 2023-12-31)
ROE: -2489.165969133146%
Net margin: -14.577500631693285%
Asset turnover: 4.356259984778534
Equity multiplier (leverage): 39.19737601505543
EBIT margin: -14.788452445848119%
ROE archetype: Low Return
DuPont ROE decomposition for JYD (annual period ending 2024-12-31)
ROE: -187.238461184398%
Net margin: -8.769241971704963%
Asset turnover: 3.9323262222144795
Equity multiplier (leverage): 5.429795460170347
EBIT margin: -9.563804282294319%
ROE archetype: Low Return
DuPont ROE decomposition for JZCP.L (quarterly period ending 2025-02-28)
Equity multiplier (leverage): 1.0028179782644313
ROE archetype: Standard Business
DuPont ROE decomposition for JZCP.L (quarterly period ending 2025-08-31)
Equity multiplier (leverage): 1.0027912647110453
ROE archetype: Standard Business
DuPont ROE decomposition for JZCP.L (quarterly period ending 2026-02-28)
Equity multiplier (leverage): 1.0025199538582865
ROE archetype: Standard Business
DuPont ROE decomposition for JZR.V (quarterly period ending 2024-09-30)
ROE: -1.4932712609509868%
Asset turnover: 0
Equity multiplier (leverage): 1.2658468412937642
ROE archetype: Low Return